Metraipolis › archive › dc_89ae46803e82

Cost-effectiveness analysis of adebrelimab in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer — Europe PMC PMID:40512778

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40512778
DOI
10.1371/journal.pone.0325171
License (as archived)
solo-consultazione
Archived
2026-10-07T23:47:09.951Z
SHA-256 of the archived text
96e0d4d2403904e2e04a1bd42cc72bd8c097c2afbe76503fbd9b5385c8dcdc6b
Stable URL of this page
https://metraipolis.com/documento/dc_89ae46803e82

How to cite

Cost-effectiveness analysis of adebrelimab in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer — Europe PMC PMID:40512778 — Europe PMC (en), https://europepmc.org/article/MED/40512778 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_89ae46803e82 (Metraipolis archive dc_89ae46803e82, sha256 96e0d4d2403904e2e04a1bd42cc72bd8c097c2afbe76503fbd9b5385c8dcdc6b)
BibTeX
@misc{dc89ae46803e82,
  title = {Cost-effectiveness analysis of adebrelimab in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer — Europe PMC PMID:40512778},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40512778},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_89ae46803e82; sha256 96e0d4d2403904e2e04a1bd42cc72bd8c097c2afbe76503fbd9b5385c8dcdc6b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40512778. Agents can read the archived copy with the MCP tool read_document.